Insider Transactions in Q1 2017 at Johnson & Johnson (JNJ)
Insider Transaction List (Q1 2017)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2017
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Open market or private sale
|
Direct |
50,000
-42.18%
|
$6,150,000
$123.62 P/Share
|
|
Mar 03
2017
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+18.97%
|
$3,000,000
$60.04 P/Share
|
|
Feb 28
2017
|
Gary J Pruden Exec VP, WW Chair, Med Devices |
SELL
Open market or private sale
|
Direct |
16,299
-27.2%
|
$1,988,478
$122.21 P/Share
|
|
Feb 28
2017
|
Ronald A Kapusta Controller, CAO |
SELL
Open market or private sale
|
Direct |
14,543
-32.68%
|
$1,774,246
$122.25 P/Share
|
|
Feb 28
2017
|
Ronald A Kapusta Controller, CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,543
+24.63%
|
$1,047,096
$72.54 P/Share
|
|
Feb 27
2017
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Bona fide gift
|
Direct |
208
-0.19%
|
-
|
|
Feb 15
2017
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Open market or private sale
|
Direct |
22,000
-14.7%
|
$2,574,000
$117.29 P/Share
|
|
Feb 13
2017
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,961
-14.59%
|
$1,260,515
$115.67 P/Share
|
|
Feb 13
2017
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,224
+7.65%
|
-
|
|
Feb 13
2017
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,598
+18.46%
|
-
|
|
Feb 13
2017
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
54,274
-17.27%
|
$6,241,510
$115.67 P/Share
|
|
Feb 13
2017
|
Alex Gorsky Director |
BUY
Grant, award, or other acquisition
|
Direct |
33,635
+9.67%
|
-
|
|
Feb 13
2017
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
84,299
+23.1%
|
-
|
|
Feb 13
2017
|
Sandra E Peterson Exec VP, Group WW Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
21,715
-26.98%
|
$2,497,225
$115.67 P/Share
|
|
Feb 13
2017
|
Sandra E Peterson Exec VP, Group WW Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
11,039
+12.06%
|
-
|
|
Feb 13
2017
|
Sandra E Peterson Exec VP, Group WW Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
27,667
+28.49%
|
-
|
|
Feb 13
2017
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
17,027
-10.22%
|
$1,958,105
$115.67 P/Share
|
|
Feb 13
2017
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Grant, award, or other acquisition
|
Direct |
10,552
+5.95%
|
-
|
|
Feb 13
2017
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
26,447
+14.49%
|
-
|
|
Feb 13
2017
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
10,591
-8.78%
|
$1,217,965
$115.67 P/Share
|
|
Feb 13
2017
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5,825
+4.6%
|
-
|
|
Feb 13
2017
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,600
+11.28%
|
-
|
|
Feb 13
2017
|
Ronald A Kapusta Controller, CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
945
-3.06%
|
$108,675
$115.67 P/Share
|
|
Feb 13
2017
|
Ronald A Kapusta Controller, CAO |
BUY
Grant, award, or other acquisition
|
Direct |
857
+2.7%
|
-
|
|
Feb 13
2017
|
Ronald A Kapusta Controller, CAO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,148
+6.67%
|
-
|
|
Feb 13
2017
|
Gary J Pruden Exec VP, WW Chair, Med Devices |
SELL
Payment of exercise price or tax liability
|
Direct |
9,673
-13.9%
|
$1,112,395
$115.67 P/Share
|
|
Feb 13
2017
|
Gary J Pruden Exec VP, WW Chair, Med Devices |
BUY
Grant, award, or other acquisition
|
Direct |
6,197
+8.18%
|
-
|
|
Feb 13
2017
|
Gary J Pruden Exec VP, WW Chair, Med Devices |
BUY
Exercise of conversion of derivative security
|
Direct |
15,532
+19.68%
|
-
|
|
Feb 13
2017
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
16,175
-19.09%
|
$1,860,125
$115.67 P/Share
|
|
Feb 13
2017
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Grant, award, or other acquisition
|
Direct |
8,897
+9.5%
|
-
|
|
Feb 13
2017
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
22,298
+22.73%
|
-
|
|
Feb 13
2017
|
Dominic J Caruso Exec VP, Finance; CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
17,350
-10.75%
|
$1,995,250
$115.67 P/Share
|
|
Feb 13
2017
|
Dominic J Caruso Exec VP, Finance; CFO |
BUY
Grant, award, or other acquisition
|
Direct |
10,752
+6.24%
|
-
|
|
Feb 13
2017
|
Dominic J Caruso Exec VP, Finance; CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
26,947
+15.17%
|
-
|
|
Feb 10
2017
|
Dominic J Caruso Exec VP, Finance; CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,699
-2.9%
|
$425,385
$115.13 P/Share
|
|
Feb 10
2017
|
Dominic J Caruso Exec VP, Finance; CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,779
+7.8%
|
-
|
|
Feb 10
2017
|
Joaquin Duato CEO and Chairman of the Board |
SELL
Payment of exercise price or tax liability
|
Direct |
3,363
-5.91%
|
$386,745
$115.13 P/Share
|
|
Feb 10
2017
|
Joaquin Duato CEO and Chairman of the Board |
BUY
Exercise of conversion of derivative security
|
Direct |
8,919
+13.56%
|
-
|
|
Feb 10
2017
|
Peter Fasolo Exec VP, Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,345
-4.21%
|
$269,675
$115.13 P/Share
|
|
Feb 10
2017
|
Peter Fasolo Exec VP, Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,239
+10.08%
|
-
|
|
Feb 10
2017
|
Alex Gorsky Director |
SELL
Payment of exercise price or tax liability
|
Direct |
14,251
-6.77%
|
$1,638,865
$115.13 P/Share
|
|
Feb 10
2017
|
Alex Gorsky Director |
BUY
Exercise of conversion of derivative security
|
Direct |
33,720
+13.8%
|
-
|
|
Feb 10
2017
|
Sandra E Peterson Exec VP, Group WW Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
4,942
-10.58%
|
$568,330
$115.13 P/Share
|
|
Feb 10
2017
|
Sandra E Peterson Exec VP, Group WW Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
11,067
+19.15%
|
-
|
|
Feb 10
2017
|
Gary J Pruden Exec VP, WW Chair, Med Devices |
SELL
Payment of exercise price or tax liability
|
Direct |
1,970
-3.95%
|
$226,550
$115.13 P/Share
|
|
Feb 10
2017
|
Gary J Pruden Exec VP, WW Chair, Med Devices |
BUY
Exercise of conversion of derivative security
|
Direct |
6,213
+11.08%
|
-
|
|
Feb 10
2017
|
Paulus Stoffels Vice Chair, Exec Committee |
SELL
Payment of exercise price or tax liability
|
Direct |
3,600
-2.7%
|
$414,000
$115.13 P/Share
|
|
Feb 10
2017
|
Paulus Stoffels Vice Chair, Exec Committee |
BUY
Exercise of conversion of derivative security
|
Direct |
10,579
+7.35%
|
-
|
|
Feb 10
2017
|
Michael H Ullmann Exec VP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
3,029
-2.93%
|
$348,335
$115.13 P/Share
|
|
Feb 10
2017
|
Michael H Ullmann Exec VP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,840
+5.35%
|
-
|